Delayed haemolytic transfusion reaction in adults with sickle cell disease: A 5-year experience

British Journal of Haematology

Volumn 169, Issue 5, 2015, Pages 746-753

  Vidler, Jennifer B ^a,b   Gardner, Kate ^a,b   Amenyah, Kenneth ^b   Mijovic, Aleksandar ^b   Thein, Swee L ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute pain episode; Allo antibodies; Delayed haemolytic transfusion reaction; Hyperhaemolysis; Sickle cell disease

Indexed keywords

ALLOANTIBODY; ANTIANEMIC AGENT; AUTOANTIBODY; IMMUNOGLOBULIN; IRON; METHYLPREDNISOLONE; RITUXIMAB; STEROID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ALLOIMMUNITY; ARTICLE; BLOOD TRANSFUSION REACTION; CLINICAL ARTICLE; DELAYED HEMOLYTIC TRANSFUSION REACTION; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HEMOGLOBINURIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PAIN; PRIORITY JOURNAL; RETICULOCYTOPENIA; SICKLE CELL ANEMIA; YOUNG ADULT; ADVERSE EFFECTS; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; COMPLICATION; HYPERSENSITIVITY, DELAYED; RETROSPECTIVE STUDY; TRANSFUSION REACTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSFUSION REACTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84929266183     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13339     Document Type: Article

References (17)

1. Aygun, B., Padmanabhan, S., Paley, C. & Chandrasekaran, V. (2002) Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion, 42, 37-43.
2. British Committee for Standards in Haematology, Milkins, C., Berryman, J., Cantwell, C., Elliott, C., Haggas, R., Jones, J., Rowley, M., Williams, M. & Win, N. (2013) Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfusion Medicine (Oxford, England), 23, 3-35.
3. Davey, R.J., Gustafson, M. & Holland, P.V. (1980) Accelerated immune red cell destruction in the absence of serologically detectable alloantibodies. Transfusion, 20, 348-353.
4. Diamond, W.J., Brown, Jr, F.L., Bitterman, P., Klein, H.G., Davey, R.J. & Winslow, R.M. (1980) Delayed hemolytic transfusion reaction presenting as sickle-cell crisis. Annals of Internal Medicine, 93, 231-234.
5. Drasar, E., Igbineweka, N., Vasavda, N., Free, M., Awogbade, M., Allman, M., Mijovic, A. & Thein, S.L. (2011) Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years. British Journal of Haematology, 152, 766-770.
6. El-Husseini, A. & Sabry, A. (2010) Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: a case report and literature review. American Journal of Emergency Medicine, 28, e1065-e1068.
7. Fasano, R.M., Booth, G.S., Miles, M., Du, L., Koyama, T., Meier, E.R. & Luban, N.L. (2015) Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease. British Journal of Haematology, 168, 291-300.
8. King, K.E., Shirey, R.S., Lankiewicz, M.W., Young-Ramsaran, J. & Ness, P.M. (1997) Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion, 37, 376-381.
9. de Montalembert, M., Dumont, M.D., Heilbronner, C., Brousse, V., Charrara, O., Pellegrino, B., Piguet, C., Soussan, V. & Noizat-Pirenne, F. (2011) Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica, 96, 801-807.
10. Murao, M. & Viana, M.B. (2005) Risk factors for alloimmunization by patients with sickle cell disease. Brazilian Journal of Medical and Biological Research, 38, 675-682.
11. Petz, L.D., Calhoun, L., Shulman, I.A., Johnson, C. & Herron, R.M. (1997) The sickle cell hemolytic transfusion reaction syndrome. Transfusion, 37, 382-392.
12. Reisner, E.G., Kostyu, D.D., Phillips, G., Walker, C. & Dawson, D.V. (1987) Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens, 30, 161-166.
13. Schonewille, H., van de Watering, L.M., Loomans, D.S. & Brand, A. (2006) Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion, 46, 250-256.
14. Talano, J.A., Hillery, C.A., Gottschall, J.L., Baylerian, D.M. & Scott, J.P. (2003) Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics, 111, e661-e665.
15. Vichinsky, E.P., Earles, A., Johnson, R.A., Hoag, M.S., Williams, A. & Lubin, B. (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New England Journal of Medicine, 322, 1617-1621.
16. Yazdanbakhsh, K., Ware, R.E. & Noizat-Pirenne, F. (2012) Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood, 120, 528-537.
17. Yazer, M.H., Triulzi, D.J., Shaz, B., Kraus, T. & Zimring, J.C. (2009) Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization? Transfusion, 49, 1070-1075.